Long-term outcome of children with acute promyelocytic leukemia: a randomized study of oral versus intravenous arsenic by SCCLG-APL group.
Huang DP, Yang LC, Chen YQ, Wan WQ, Zhou DH, Mai HR, Li WL, Yang LH, Lan HK, Chen HQ, Guo BY, Zhen ZJ, Liu RY, Chen GH, Feng XQ, Liang C, Wang LN, Li Y, Luo JS, Fan Z, Luo XQ, Li B, Tang YL, Zhang XL, Huang LB.
Huang DP, et al. Among authors: yang lc.
Blood Cancer J. 2023 Dec 5;13(1):178. doi: 10.1038/s41408-023-00949-w.
Blood Cancer J. 2023.
PMID: 38052803
Free PMC article.
Clinical Trial.
All 4 relapses occurred within 1.5 years after completion of maintenance therapy. No long-term arsenic retentions were observed in either group. Substituting oral RIF for ATO maintains treatment efficacy while reducing hospitalization and adverse events in treating pediatr …
All 4 relapses occurred within 1.5 years after completion of maintenance therapy. No long-term arsenic retentions were observed in ei …